-
Aclaris Therapeutics (NASDAQ:ACRS) Rating Increased to Strong-Buy at Cantor Fitzgerald
来源: Buzz FX / 01 2月 2025 05:11:10 America/Chicago
Aclaris Therapeutics (NASDAQ:ACRS) Rating Increased to Strong-Buy at Cantor Fitzgerald Written by MarketBeat February 1, 2025 Share Link copied to clipboard. Aclaris Therapeutics ( NASDAQ:ACRS - Get Free Report ) was upgraded by analysts at
Read more...